Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452

Hendrik Luesch; Wesley Y. Yoshida; Richard E. Moore; Valerie J. Paul; Susan L. Mooberry; Thomas H. Corbett

doi:10.1021/np010317s

Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452

Hendrik Luesch, Wesley Y. Yoshida, Richard E. Moore, Valerie J. Paul, Susan L. Mooberry, Thomas H. Corbett

Pharmacology

Research output: Contribution to journal › Article › peer-review

71 Scopus citations

Abstract

Symplostatin 3 (1), a new analogue of dolastatin 10 (2), has been isolated from a tumor selective extract of a Hawaiian variety of the marine cyanobacterium Symploca sp. VP452. Compound 1 differs from 2 only in the C-terminal unit; the dolaphenine unit is substituted by a 3-phenyllactic acid residue. Symplostatin 3 (1) possesses IC₅₀ values for in vitro cytotoxicity toward human tumor cell lines ranging from 3.9 to 10.3 nM. It disrupts microtubules, but at a higher concentration than 2, correlating with the weaker in vitro cytotoxicity.

Original language	English (US)
Pages (from-to)	16-20
Number of pages	5
Journal	Journal of Natural Products
Volume	65
Issue number	1
DOIs	https://doi.org/10.1021/np010317s
State	Published - 2002

ASJC Scopus subject areas

Analytical Chemistry
Molecular Medicine
Pharmacology
Pharmaceutical Science
Drug Discovery
Complementary and alternative medicine
Organic Chemistry

Access to Document

10.1021/np010317s

Fingerprint Dive into the research topics of 'Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452'. Together they form a unique fingerprint.

Cite this

@article{ba19bf2f94e543aa8c3661b70d2b015c,

title = "Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452",

abstract = "Symplostatin 3 (1), a new analogue of dolastatin 10 (2), has been isolated from a tumor selective extract of a Hawaiian variety of the marine cyanobacterium Symploca sp. VP452. Compound 1 differs from 2 only in the C-terminal unit; the dolaphenine unit is substituted by a 3-phenyllactic acid residue. Symplostatin 3 (1) possesses IC50 values for in vitro cytotoxicity toward human tumor cell lines ranging from 3.9 to 10.3 nM. It disrupts microtubules, but at a higher concentration than 2, correlating with the weaker in vitro cytotoxicity.",

author = "Hendrik Luesch and Yoshida, {Wesley Y.} and Moore, {Richard E.} and Paul, {Valerie J.} and Mooberry, {Susan L.} and Corbett, {Thomas H.}",

year = "2002",

doi = "10.1021/np010317s",

language = "English (US)",

volume = "65",

pages = "16--20",

journal = "Journal of Natural Products",

issn = "0163-3864",

publisher = "American Chemical Society",

number = "1",

}

TY - JOUR

T1 - Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452

AU - Luesch, Hendrik

AU - Yoshida, Wesley Y.

AU - Moore, Richard E.

AU - Paul, Valerie J.

AU - Mooberry, Susan L.

AU - Corbett, Thomas H.

PY - 2002

Y1 - 2002

N2 - Symplostatin 3 (1), a new analogue of dolastatin 10 (2), has been isolated from a tumor selective extract of a Hawaiian variety of the marine cyanobacterium Symploca sp. VP452. Compound 1 differs from 2 only in the C-terminal unit; the dolaphenine unit is substituted by a 3-phenyllactic acid residue. Symplostatin 3 (1) possesses IC50 values for in vitro cytotoxicity toward human tumor cell lines ranging from 3.9 to 10.3 nM. It disrupts microtubules, but at a higher concentration than 2, correlating with the weaker in vitro cytotoxicity.

AB - Symplostatin 3 (1), a new analogue of dolastatin 10 (2), has been isolated from a tumor selective extract of a Hawaiian variety of the marine cyanobacterium Symploca sp. VP452. Compound 1 differs from 2 only in the C-terminal unit; the dolaphenine unit is substituted by a 3-phenyllactic acid residue. Symplostatin 3 (1) possesses IC50 values for in vitro cytotoxicity toward human tumor cell lines ranging from 3.9 to 10.3 nM. It disrupts microtubules, but at a higher concentration than 2, correlating with the weaker in vitro cytotoxicity.

UR - http://www.scopus.com/inward/record.url?scp=0036165655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036165655&partnerID=8YFLogxK

U2 - 10.1021/np010317s

DO - 10.1021/np010317s

M3 - Article

C2 - 11809057

AN - SCOPUS:0036165655

VL - 65

SP - 16

EP - 20

JO - Journal of Natural Products

JF - Journal of Natural Products

SN - 0163-3864

IS - 1

ER -

Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this